Combined hormonal contraception and venous thromboembolism (Q36845040)

16 August 2017

1 reference

title

Combined hormonal contraception and venous thromboembolism (English)

1 reference

combined hormonal contraception

16 August 2017

1 reference

venous thromboembolism

1 reference

based on heuristic

inferred from title

1 reference

Francisca Martínez

1

1 reference

16 August 2017

Angels Avecilla

series ordinal

2

1 reference

16 August 2017

publication date

1 June 2007

1 reference

The European Journal of Contraception Reproductive Health Care

16 August 2017

published in

1 reference

16 August 2017

volume

12

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

97-106

1 reference

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Third generation oral contraceptives and risk of venous thrombosis: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Venous thrombosis: a multicausal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Mortality in relation to oral contraceptive use and cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

The effects of a low-dose monophasic preparation of levonorgestrel and ethinyl estradiol on coagulation and other hemostatic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Comparison of incidence/risk of venous thromboembolism (VTE) among selected clinical and hereditary risk markers: a community-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Oral contraceptives and the risk of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

The collection and interpretation of epidemiological data about the cardiovascular risks associated with the use of steroid contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Hemostatic effects of third- and second-generation oral contraceptives: absence of a causal mechanism for a difference in risk of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

APC resistance and third-generation oral contraceptives: Acquired resistance to activated protein C, oral contraceptives and the risk of thromboembolic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

The association between extrinsic activated protein C resistance and venous thromboembolism in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Sex hormone--binding globulin--a surrogate marker for the prothrombotic effects of combined oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Oral contraceptives and venous thromboembolism: a five-year national case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

The thrombophilias: well-defined risk factors with uncertain therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a meta-analysis and formal sensitivity analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Pharmacokinetic overview of Ortho Evra/Evra

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Efficacy and safety of a transdermal contraceptive system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Thromboembolism associated with the new contraceptive Yasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Safety of a new oral contraceptive containing drospirenone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Progestogen-only contraception in women at high risk of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Mortality from venous thromboembolism in young Swedish women and its relation to pregnancy and use of oral contraceptives--an approach to specifying rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Factor V Leiden: should we screen oral contraceptive users and pregnant women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

Long term use of oral contraceptives without thrombosis in patients with FV Leiden polymorphism: a study of 37 patients (2 homozygous and 35 heterozygous).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701300194

10.1080/13625180701300194

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference